- Stocks Telegraph Morning
- Posts
- 10 Jan - NH - Morning Newsletter (with survey at top and bottom)
10 Jan - NH - Morning Newsletter (with survey at top and bottom)
4 Skyrocketing Stocks To Trade Today
The Newsheater daily morning newsletter is powered by Stocks Telegraph
Help us improve newsletter by taking
Good Morning!Futures for US stock indices are falling on Tuesday in anticipation of the speech of the head of the US Federal Reserve System (FRS) Jerome Powell.Futures for the Dow Jones Industrial Index (DJIA) are down 0.2% to 33,603 points, futures for the NASDAQ high-tech index - by 0.02%, to 11,183.25 points, and the S&P broad market index 500 - by 0.08%, up to 3910.75 points.Investors are awaiting comments from US Federal Reserve Chairman Jerome Powell on Tuesday evening.In addition, traders are waiting for US consumer price data to be released on Thursday. Analysts believe that annual inflation in the country has slowed down to 6.5% from 7.1% per annum recorded in November.
Lithium Crisis Is Real And This Is Great News For Investors
Washington is demanding 50% of all vehicles on the road be electric or hybrid vehicles by 2030. All those green energy vehicles need lithium batteries. There's just one problem: a serious shortfall in the lithium supply.
According to experts, the demand for lithium used in the batteries for EVs is huge but there is a grave shortfall of this precious mineral.
Sponsored
Today Top Movers
Sotera Health Company (SHC) stock soared 52.89% to $13.21 in the pre-market trading after announcing settlement of Ethylene Oxide Litigation in Illinois.
Frontline plc (NYSE: FRO) shares are trading up 24.45% at $14.1 at the time of writing following the termination of combination agreement with Euronav
VYNE Therapeutics Inc. (VYNE) grew over 58.85% at $0.305 in pre-market trading today. The company reported first Vitiligo patient dosed in phase 1a/b clinical trial of Novel BET Inhibitor VYN201.
Oak Street Health Inc. (OSH), a Medical Care Facilities company, rose about 31.15% at $29.6 in pre-market trading Tuesday following a report that OSH to agree a $10 billion takeover by CVS Health (CVS)
The Smart Way to Get Insanely Rich in the 2023 Gold Bull Market
The 2023 gold bull market has arrived as nervous investors continue to flock to the safety of the yellow metal. Yet, the biggest gains won't be in gold...they'll be in select gold stocks with proven ounces in the ground. This soon-to-be-known gold company provides investors with exposure to over 30 million ounces of gold...worth tens of $Billions...at a ridiculously low US$1 per share.
Sponsored
Top Upgrades & Downgrades
UBS turned bullish on NXP Semiconductors N.V. (NXPI), upgrading the stock to "Neutral" and assigning a $167 price target, representing potential upside of 3.75% from Monday's close.
AT&T Inc. (T) has won the favor of Wells Fargo's equity research team. The firm upgraded the shares from Equal-Weight to Overweight and moved their price target to $22, suggesting 15.49% additional upside for the stock.
ONEOK Inc. (OKE) received an upgrade from analysts at JP Morgan, who also set their one-year price target on the stock to $75. They changed their rating on OKE to Overweight from Neutral in a recently issued research note.
Earlier Tuesday Mizuho reduced its rating on Chevron Corporation (CVX) stock to Neutral from Buy and assigned the price target to $200.
Mizuho analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Phillips 66 (PSX) has been changed to Neutral from Buy and the new price target is set at $121.
Analysts at Jefferies downgraded Ally Financial Inc. (ALLY)'s stock to Hold from Buy Tuesday.
The New Energy Crisis No One Saw Coming
Free investor report reveals how the electric car initiative is putting the U.S. in peril...and shows how to potentially capitalize on this crisis with a junior mining company.
Sponsored
Latest Insider Activity
Tesla Inc. (TSLA) Chief Financial Officer Kirkhorn Zachary announced the sale of shares taking place on Jan 04 at $109.31 for some 3,752 shares. The total came to more than $0.41 million.
Meta Platforms Inc. (META) Chief Legal Officer Newstead Jennifer sold on Jan 04 a total 342 shares at $127.40 on average. The insider’s sale generated proceeds of almost $43571.0.
Jaguar Health Inc. (JAGX) Chief of Staff, CCO & GC Wolin Jonathan S. declared the purchase of shares taking place on Dec 31 at $0.03 for some 317 shares. The transaction amount was around $10.0.
CrowdStrike Holdings Inc. (CRWD) Director AUSTIN ROXANNE S bought on Jan 05 a total 35,000 shares at $96.19 on average. The purchase cost the insider an estimated $3.37 million.
These 5 Tech Stocks Have 10x Potential
If you had bought Netflix after the dot-com crash, you could have turned $1,000 into over half a million dollars in profit. And today – thanks to the tech crash – you have a similar opportunity. Luke Lango just named 5 tech stocks with 10x potential in a new report (one is trading for just $6).
Sponsored
Important Earnings
Top US earnings releases scheduled for today include Bed Bath & Beyond Inc. (NASDAQ: BBBY). It will announce its Nov 2022 financial results. The company is expected to report earnings of -$2.11 per share from revenues of $1.34B in the three-month period.
Analysts expect Albertsons Companies Inc. (NYSE: ACI) to report a net income (adjusted) of $0.67 per share, when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Nov 2022 is predicted to come in at $17.64B.
Inotiv Inc. (NOTV), due to announce earnings after the market closes today, is expected to report earnings of -$0.37 per share from revenues of $152.96M recently concluded three-month period.
That's it for today. Thanks for reading. Good luck out there!Best Regards,Stocks Telegraph Team
P.S. Want my daily watchlists sent to your cell phone too? Just go HERE and join my text message list!
Wouldn’t it be great to have a personalized solution for your investing needs? We’re adding new sections to the morning newsletter with big implications. All you have to do is share your thought about the current newsletter. If you do that, we’ll do our best to take your feedback and make it a better experience for you.
We are asking for 1 minute of your time to answer 4 questions about your experience with our newsletter. We hope to use this information to create solutions that address exactly what you need!
Thank you for your continued support.
Disclaimer: Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails.